Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway

Fig. 1

Colchicine improves cardiac dysfunction caused by CME. (A) The representative echocardiography in each group. (B) The measurement results of left ventricular end-diastolic diameter (LVEDd), left ventricular endystolic diameter (LVESd), left ventricular ejection fraction (LVEF), and left ventricular fractional shortening (LVFS) (n = 5 per group). *p<0.05 versus Sham group; &p<0.05 versus CME group; #p<0.05 versus CME + COL group

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us